ENvue Medical (FRA:56R1) Cyclically Adjusted Book per Share: €-279.96 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:56R1 ENvue Medical Inc FRA:56R1
37 GF Score
Price €6.20
GF Value €72.47
! 4 Warning Signs
View Full Analysis

What is ENvue Medical Cyclically Adjusted Book per Share?

ENvue Medical FRA:56R1 37 Cyclically Adjusted Book per Share is €-279.96 as of Mar. 2026. GuruFocus rates FRA:56R1 with a GF Score™ of 37/100 and a GF Value™ of €72.47. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

ENvue Medical's adjusted book value per share for the three months ended in Mar. 2026 was €7.483. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €-279.96 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 43.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of ENvue Medical was 43.30% per year. The lowest was 43.30% per year. And the median was 43.30% per year.

As of today (2026-08-19), ENvue Medical's current stock price is €6.20. ENvue Medical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €-279.96. ENvue Medical's Cyclically Adjusted PB Ratio of today is .


ENvue Medical  (FRA:56R1) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


ENvue Medical Cyclically Adjusted Book per Share Related Terms


ENvue Medical Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for ENvue Medical's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENvue Medical Cyclically Adjusted Book per Share Chart

ENvue Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -60.15 -185.60 -64.45 -339.15

ENvue Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -117.32 -106.01 -148.03 -339.15 -279.96

FRA:56R1 vs BTCY, VYCO, ADMT: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, ENvue Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ENvue Medical Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ENvue Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where ENvue Medical's Cyclically Adjusted PB Ratio falls into.


FRA:56R1
37GF Score
ENvue Medical Inc FRA:56R1
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ENvue Medical Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ENvue Medical's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=7.483/330.2130*330.2130
=7.483

Current CPI (Mar. 2026) = 330.2130.

ENvue Medical Quarterly Data

Book Value per Share CPI Adj_Book
201606 -1,034.000 241.018 -1,416.659
201609 -1,430.000 241.428 -1,955.882
201612 -2,371.000 241.432 -3,242.880
201703 -2,623.000 243.801 -3,552.687
201706 -2,717.000 244.955 -3,662.668
201709 -3,600.000 246.819 -4,816.350
201712 1,534.500 246.524 2,055.426
201803 1,197.000 249.554 1,583.885
201806 949.000 251.989 1,243.595
201809 593.000 252.439 775.698
201812 202.500 251.233 266.160
201903 -208.500 254.202 -270.845
201906 854.000 256.143 1,100.955
201909 1,010.500 256.759 1,299.585
201912 604.500 256.974 776.786
202003 223.500 258.115 285.929
202006 -350.000 257.797 -448.316
202009 461.833 260.280 585.920
202012 196.600 260.474 249.237
202103 331.727 264.877 413.553
202106 314.000 271.696 381.628
202109 616.833 274.310 742.540
202112 429.769 278.802 509.018
202203 367.462 287.504 422.049
202206 300.846 296.311 335.267
202209 245.077 296.808 272.660
202212 203.467 296.797 226.375
202303 137.200 301.836 150.099
202306 71.667 305.109 77.564
202309 258.529 307.789 277.364
202312 192.474 306.746 207.199
202403 128.960 312.332 136.343
202406 105.560 314.175 110.949
202409 67.480 315.301 70.671
202412 15.763 315.605 16.493
202503 434.197 319.799 448.336
202506 44.592 322.561 45.650
202509 35.785 324.800 36.381
202512 26.005 324.054 26.499
202603 7.483 330.213 7.483

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €-279.96 mean?
ENvue Medical (FRA:56R1) has a Cyclically Adjusted Book per Share of €-279.96 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on ENvue Medical and its competitors.
Is ENvue Medical's Cyclically Adjusted Book per Share too high?
ENvue Medical's current Cyclically Adjusted Book per Share is €-279.96. Overall, ENvue Medical has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does ENvue Medical's Cyclically Adjusted Book per Share compare to BTCY and VYCO?
ENvue Medical's Cyclically Adjusted Book per Share of €-279.96 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on ENvue Medical and its competitors. ENvue Medical's current Cyclically Adjusted Book per Share is €-279.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENvue Medical stock overvalued right now?
ENvue Medical (FRA:56R1) has a current Cyclically Adjusted Book per Share of €-279.96. The stock's GF Value™ is €72.47, compared to a current price of €6.20 — trading 91.4% below its estimated fair value. The current Cyclically Adjusted Book per Share is €-279.96. ENvue Medical's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For ENvue Medical (FRA:56R1), the current Cyclically Adjusted Book per Share is €-279.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ENvue Medical (FRA:56R1) Overvalued in 2026?

Based on GuruFocus' analysis, ENvue Medical stock appears to be undervalued. The current stock price of €6.20 is trading 91.4% below its estimated GF Value™ of €72.47.

Key valuation signals for FRA:56R1:

  • Cyclically Adjusted Book per Share: €-279.96
  • GF Value™: €72.47 vs. price of €6.20 (91.4% below fair value)
  • GF Score™: 37/100 with 4 warning signs

No single metric tells the full story. See the FRA:56R1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ENvue Medical Business Description

Other Exchanges FEED:USA
Address 969 Pruitt Avenue, Tyler, TX, USA, 77569
ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes.
37GF Score

Get the complete analysis for FRA:56R1

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.20
Price
€72.47
GF Value